GTG 25.0% 0.6¢ genetic technologies limited

Pfizer taker over?

  1. 1,388 Posts.
    lightbulb Created with Sketch. 4
    http://sierraworldequityreview.blogspot.com.au/2015/02/pfizer-pfe-to-acquire-genetic.html

    Pfizer (PFE) To Acquire Genetic Technologies (GENE) Following Ibrance FDA Approval For ER-Positive, HER2-negative Breast Cancer Predicts Sierra Equity
    Latest Projections: Pfizer (PFE) To Acquire Genetic Technologies (GENE) Following Ibrance FDA Approval For ER-Positive, HER2-negative Breast Cancer Predicts Sierra Equity. Look for the share price of GENE to start moving higher as potential buyout talks happen in NYC this month forecasts Sierra. Check back as Sierra follows her leads! Look for the official news coming, when it breaks remember Sierra called this first!
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
-0.00(25.0%)
Mkt cap $21.15M
Open High Low Value Volume
0.7¢ 0.7¢ 0.6¢ $104.6K 15.24M

Buyers (Bids)

No. Vol. Price($)
25 12150851 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 2418403 3
Last update - 16.10pm 18/12/2018 (20 minute delay) ?
(live)
Last
0.7¢
  Change
-0.00 ( 12.5 %)
Open High   Low Volume
0.7¢ 0.7¢   0.6¢ 3463578
Last updated 15.01pm 18/12/2018 (live) ?
GTG (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.